RemSleep Holdings (RMSL) Net Cash Flow (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -79.70% |
| Sep 30, 2025 | 21.09% |
| Jun 30, 2025 | -307.89% |
| Mar 31, 2025 | 161.52% |
| Dec 31, 2024 | 20.97% |
| Sep 30, 2024 | -183.13% |
| Jun 30, 2024 | -376.77% |
| Mar 31, 2024 | 106.22% |
| Dec 31, 2023 | -4.14% |
| Sep 30, 2023 | 53.49% |
| Jun 30, 2023 | -1.41% |
| Mar 31, 2023 | -18.26% |
| Dec 31, 2022 | -37.23% |
| Sep 30, 2022 | 85.66% |
| Jun 30, 2022 | -356.92% |
| Mar 31, 2022 | -38.11% |
| Dec 31, 2021 | -49.35% |
| Sep 30, 2021 | 948.35% |
| Jun 30, 2021 | 330.09% |
| Mar 31, 2021 | 156.75% |
| Dec 31, 2020 | -64.58% |
| Sep 30, 2020 | 123.84% |
| Jun 30, 2020 | -253.57% |
| Mar 31, 2020 | 649.67% |
| Dec 31, 2019 | 122.34% |
| Sep 30, 2019 | -158.27% |
| Jun 30, 2019 | 395.85% |
| Mar 31, 2019 | 213.97% |
| Dec 31, 2018 | -160.18% |
| Sep 30, 2018 | 178.13% |
| Jun 30, 2018 | -202.91% |
| Mar 31, 2018 | 2,464.93% |
| Dec 31, 2017 | -35.88% |
| Sep 30, 2017 | 201.83% |
| Sep 30, 2016 | 78.95% |
| Jun 30, 2016 | -46.15% |
| Mar 31, 2016 | 99.54% |
| Dec 31, 2013 | 115.02% |
| Sep 30, 2013 | 99.91% |
| Jun 30, 2013 | -393,564.41% |
| Mar 31, 2013 | 100.26% |
| Dec 31, 2012 | -100.54% |
| Sep 30, 2012 | 200.52% |
| Jun 30, 2012 | -634,928.78% |
| Mar 31, 2012 | 93.60% |
| Dec 31, 2011 | -186.25% |